Future Market Insights opines the food botanicals market is at a bifurcation point between bulk commodity extraction and clinical-grade bioactive ingredients, where manufacturers anchored in commodity volumes face structural margin compression as regulated health claim positioning commands measurably higher returns across beverage, supplement, and functional food channels.